Molecular Analysis of A2-genes Encoding Stage-specific S Antigen-like Proteins among Isolates from Iranian Cutaneous and Visceral Leishmaniasis

Document Type : Original Article

Authors

1 Department of Parasitology, Pasteur Institute of Iran, Tehran, Iran

2 Department of Parasitology, Institute of Public Health Research, Tehran University of Medical Sciences, Tehran, Iran

Abstract

Objective(s)
Leishmania can lead to a broad spectrum of diseases, collectively known as leishmaniasis. The A2 gene/ protein family could be one of the most eligible candidate factors of virulence in visceral leishmaniasis (VL). The previous results confirmed that in Leishmania infantum, several A2 proteins are abundantly expressed by the amastigote, but not the promastigote stage. As there are no data available on the pattern of A2 gene / protein in Iranian Leishmania isolates of either cutaneous leishmaniasis (CL) or VL; the current study aimed to investigate molecular analysis of A2 gene in leishmania species among field isolates of Iran.
Materials and Methods
An A2 gene was identified by sequencing of crude PCR products resulting from 20 samples of CL and 10 samples of VL isolates from Iranian patients.
Results
The results indicated the A2 gene in CL is only a single copy of 153 bp encoding a protein of 51 amino acids, as opposed to A2 of VL species with multi-copy genes of varying length. A2 sequences in Iranian L. major strains represented a homology with stage-specific S antigen-like protein (A2) of L. major and L. infantum. Moreover, A2 sequences in Iranian L. tropica strains have homology with A2 protein of L. major and L. tropica.
Conclusion
It is concluded that A2 is an antigen candidate for vaccine development and diagnosis purposes and that A2 sequences are conserved among field isolates.

Keywords

References

1.Mizbani A, Taheri T, Zahedifard F, Taslimi Y, Azizi H, Azadmanesh K, et al. Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis. Vaccine 2009; 28:53-62.
2.Garin Y, Meneceure P, Pratlong F. A2 gene of old world cutaneous leishmania is a single highly conserved functional gene. BMC Infect Dis 2005; 5:18.
3.Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 2004; 27:305-318.
4.Hajjaran H, Mohebali M, Zarei Z, Edrissian GhH. Leishmania tropica: Another etiological agent of canine visceral Leishmaniasis in Iran. Iran J Public Health 2007; 36: 85-88.
5.Shahbazi F, Shahabi SH, Kazemi F, Mohebali M, Abadi A, Zare Z. Evaluation of PCR assay in diagnosis and identification of cutaneous leishmaniasis: a comparison with the parasitological methods. Parasitol Res 2008; 103:1159-1162.
6.Yaghoobi-Ershadi MR, Hanafi-Bojd AA, Javadian E, Jafari R, Zahraei-Ramazani AR, Mohebali M. A new focus of cutaneous leishmaniasis caused by Leishmania tropica. Saudi Med J 2002; 23:291-294.
7.Yaghoobi-Ershadi MR, Jafari R, Hanafi-Bojd AA. New epidemics focus of zoonotic cutaneous leishmaniasis in central Iran. Ann Saudi Med 2004; 24:98-101.
8.Gradoni L, Gramiccia M. Leishmania infantum tropism: strain genotype or host immune status? Parasitol Today 1994; 10:264-267.
9.Nahrevanian H, Farahmand M, Aghighi Z, Assmar M, Amirkhani A. Pharmacological evaluation of anti-leishmanial activity by in vivo nitric oxide modulation in Balb/c mice infected with Leishmania major MRHO/IR/75/ER; An Iranian strain of cutaneous leishmaniasis. Exp Parasitol 2007; 116:233-240.
10.Matlashewski G. Leishmania infection and virulence. Med Microbiol Immunol 2001; 190:37-42.
11.Charest H, Matlashewski G. Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote-stage-specific gene. Mol Cell Biol 1994; 14: 2975-2984
12.Zhang WW, Matlashewski G. Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein, A2. Proc Natl Acad Sci USA 1997; 94: 8807-8811.
13.Zhang WW, Matlashewski G. Characterization of the A2-A2rel gene cluster in Leishmania donovani: involvement of A2 in visceralization during infection. Mol Microbiol 2001; 39:935-948.
14.Zhang WW, Mendez S, Ghosh A, Myler P, Ivens A, Clos J, et al. Comparison of the A2 gene locus in Leishmania donovani and Leishmania major and its control over cutaneous infection. J Biol Chem 2003; 278:35508-35515.
15.Ghedin E, Zhang WW, Charest H, Sundar S, Kenney RT, Matlashewski G. Antibody response against a Leishmania donovani amastigote-stage-specific protein in patients with visceral leishmaniasis. Clin Diagn Lab Immunol 1997; 4:530-535.
16.Zhang WW, Charest H, Ghedin E, Matlashewski G. Identification and overexpression of the A2 amastigote- specific protein in Leishmania donovani. Mol Biochem Parasitol 1996; 78:79-90.
17.Ghosh A, Zhang WW, Matlashewski G. Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections. Vaccine 2001; 20:59-66.
18.Carvalho FA, Charest H, Tavares CA, Matlashewski G, Valente EP, Rabello A, et al. Diagnosis of American visceral leishmaniasis in humans and dogs using the recombinant Leishmania donovani A2 antigen. Diagn Microbiol Infect Dis 2002; 43:289-295.
19.Fernandes A, Silva Costa M. Protective immunity against challenge with Leishmania chagasi in beagle dogs vaccinated with recombinant A2 protein. Vaccine 2008; 26:5888-5895.
20.Farahmand M, Nahrevanian H, Assmar M, Mohebali M, Zarei Z. Expression of A2 proteins in amastigotes of Leishmania infantum produced from canine isolates collected in the district of Meshkinshahr, in north-western Iran. Ann Trop Med Parasitol 2008; 102:81-84. 
21.Farahmand M, Assmar M, Nahrevanian H, Farzanehnejad Z. Cutaneous leishmaniasis in patients referred to the Pasteur Institute of Iran during 2003-2006. Internet J Parasitic Dis 2008; 3(2).
22.Krobitsch S, Brandau S, Hoyer C, Schmetz C, Hubel A , Clos J. Leishmania donovani heat shock protein 100. Characterization and function in amastigote stage differentiation. J Biol Chem 1998 ; 273: 6488-6494.
23.Mohebali M, Hajjaran H, Hamzavi Y. Epidemiological aspects of canine visceral leishmaniosis in the Islamic Republic of Iran. Vet Parasitol 2005; 129:243-251.
24.Mohebali M, Javadian E, Yaghoobi-Ershadi MR, Akhavan AA, Hajjaran H, Abaei MR. Characterization of Leishmania infection in rodents from endemic areas of the Islamic Republic of Iran. East Mediterr Health J 2004; 10:591-599.
25.Ramirez JR, Agudelo S, Muskus C. Diagnosis of cutaneous leishmaniasis in Colombia: the sampling site within lesions influences the sensitivity of parasitological diagnosis. J Clin Microbiol 2000; 38:3768-3773.
26.Alborzi A, Pourabbas B, Shahian F, Mardaneh J, Pouladfar GR , Ziyaeyan M. Detection of Leishmania infantum kinetoplast DNA in the whole blood of asymptomatic individuals by PCR-ELISA and comparison with other infection markers in endemic areas, southern Iran. Am J Trop Med Hyg 2008; 79:839-842.
27.Ghedin E, Charest H, Matlashewski G. A2rel: a constitutively expressed Leishmania gene linked to an amastigote-stagespecific gene. Mol Biochem Parasitol 1998; 93:23-29.
Iranian Journal of Basic Medical Sciences
Volume 14, Issue 5 - Serial Number 5
September 2011
Pages 407-413

Files

Share

How to cite

Statistics